HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Helen Davies(Wellcome Sanger Institute), Dominik Głodzik(Wellcome Sanger Institute), Sandro Morganella(Wellcome Sanger Institute), Lucy Yates(Guy's and St Thomas' NHS Foundation Trust), Johan Staaf(Lund University), Xueqing Zou(Wellcome Sanger Institute), Manasa Ramakrishna(Wellcome Sanger Institute), Sancha Martin(Wellcome Sanger Institute), Sandrine Boyault(Centre Léon Bérard), Anieta M. Sieuwerts(Erasmus MC), Peter T. Simpson(The University of Queensland), Tari A. King(Memorial Sloan Kettering Cancer Center), Keiran Raine(Wellcome Sanger Institute), Jórunn E. Eyfjörd(University of Iceland), Gu Kong(Hanyang University), Åke Borg(Lund University), Ewan Birney(European Bioinformatics Institute), Hendrik G. Stunnenberg(Radboud University Nijmegen), Marc J. van de Vijver(Amsterdam UMC Location University of Amsterdam), Anne-Lise Børresen-Dale(Oslo University Hospital), John W.M. Martens(Erasmus MC), Paul N. Span(Radboud University Nijmegen), Sunil R. Lakhani(The University of Queensland), Anne Vincent‐Salomon(Inserm), Christos Sotiriou(Université Libre de Bruxelles), Andrew Tutt(King's College London), Alastair M. Thompson(The University of Texas MD Anderson Cancer Center), Steven Van Laere(University of Antwerp), Andrea L. Richardson(Brigham and Women's Hospital), Alain Viari(Institut national de recherche en sciences et technologies du numérique), Peter J. Campbell(Wellcome Sanger Institute), Michael R. Stratton(Wellcome Sanger Institute), Serena Nik‐Zainal(Cambridge University Hospitals NHS Foundation Trust)
Cited by 1,128Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis